Kornitzer Capital Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Kornitzer Capital Management Inc

$5.21 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$185.01 - $212.05 $4.07 Million - $4.67 Million	22,000 New	22,000 $4.18 Million
Q3 2022 Nov 03, 2022	BUY	$138.54 - $232.0 $149,623 - $250,560	1,080 New	1,080 $216,000
Q2 2022 Aug 03, 2022	SELL	$120.42 - $169.29 $404,611 - $568,814	-3,360 Closed	0 $0
Q2 2021 Jul 30, 2021	SELL	$128.63 - $176.89 $308,712 - $424,535	-2,400 Reduced 41.67%	3,360 $570,000
Q1 2021 Apr 30, 2021	SELL	$126.83 - $175.69 $7.15 Million - $9.9 Million	-56,345 Reduced 90.73%	5,760 $813,000
Q4 2020 Jan 29, 2021	SELL	$122.97 - $147.0 $3.99 Million - $4.76 Million	-32,410 Reduced 34.29%	62,105 $8.07 Million
Q3 2020 Oct 30, 2020	BUY	$121.19 - $165.49 $4.02 Million - $5.49 Million	33,202 Added 54.15%	94,515 $13.8 Million
Q2 2020 Aug 03, 2020	BUY	$104.21 - $156.44 $5.69 Million - $8.54 Million	54,593 Added 812.4%	61,313 $9.08 Million
Q4 2019 Jan 31, 2020	SELL	$74.51 - $124.23 $141,569 - $236,037	-1,900 Reduced 22.04%	6,720 $774,000
Q3 2019 Nov 04, 2019	SELL	$70.9 - $87.82 $73,027 - $90,454	-1,030 Reduced 10.67%	8,620 $693,000
Q4 2018 Jan 31, 2019	SELL	$62.67 - $88.33 $999,398 - $1.41 Million	-15,947 Reduced 62.3%	9,650 $704,000
Q3 2018 Nov 13, 2018	SELL	$87.52 - $122.67 $19.1 Million - $26.8 Million	-218,547 Reduced 89.52%	25,597 $2.24 Million
Q2 2018 Aug 02, 2018	BUY	$88.31 - $107.8 $2.68 Million - $3.27 Million	30,329 Added 14.18%	244,144 $24 Million
Q1 2018 Apr 30, 2018	BUY	$115.92 - $148.54 $273,571 - $350,554	2,360 Added 1.12%	213,815 $25.5 Million
Q4 2017 Jan 31, 2018	BUY	$114.49 - $139.98 $5.57 Million - $6.81 Million	48,620 Added 29.86%	211,455 $26.9 Million
Q3 2017 Oct 31, 2017	BUY	$72.53 - $118.27 $11.8 Million - $19.3 Million	162,835	162,835 $19.1 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$3.9 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$2.98 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.25 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.24 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.17 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account